MERRILL LYNCH carrying UNDERFORM rating with a TARGT PRICE of $20.50 !! When the Q results are reported I would guess that the ratings would begrudgingly change---as wall street estimate & targets likely go north. NOTA BAD STORY AT ALL !!!
And the primary reason is that most vanilla institutions could not hold bankrupt securities i.e AAMRQ. Interestingly as the "perfect storm" evolves for airline stocks---rational pricing, reasonable fuel costs, et al. ---there is an environment evolving from the last year or so that airlines can be INVESTED in over an economic cycle---likely one of the first times in over thirty years ! No longer is AAL the airline of that clown Bob Crandall but actually a reasonable quasi-monopolistic industry where rational thinking can prevail----and provide reasonable++ returns to investors.
Despite the outstanding performance seen in the airline sector in '13 my view is that it hasn't caught on with many investors who have always looked at this sector as trading stocks only & often too volatile for one's stomach. As the view changes simultaneously you get new institutional investors thinking that it's safe to go into the water & put $$ to work. Add on the momentum guys/chart readers/hedge funds along with rising EPS on potentially higher multiples of those earnings and you have the perfect storm-----HIGHER STOCK PRICES.
UAL, DAL & the others have all generally outperformed & are safe for the sell side of Wall Street to recommend. AAL s a different breed of cat----coming out of bankruptcy, historically poorly run, a mishmat of routs. NOW you have -- HOPEFULLY --- a management team that can handle he integration ( having done it before---though on a smaller scale), reasonable labor relations/contracts, fuel costs that look OK+, an economic backdrop that portends economic activity & more passenger traffic as a result & NO STUPID FARE WARS -- which equals pricing power & solid margins.
Based on those assumptions you have an UNDEROWNED franchise in AAL taking advantage of the same ++ industry backdrop that new $$ ---especially performance driven funds --- are looking to own. Also, as noted previously---there are big sell side firms----Bank America MERRILL LYNCH---- currently carrying
Look for WallStreet upgrades & estimate increases next week when AAL reports. BofA Merrill Lynch---currently carrying an UNDERPERFORM rating--$20.50/price objective---is likely to be one throwing in the towel & upgrading. BAML is currently carrying Street low estimates of $2.55/2014 & $3/2015----not even close to reality. After results from DAL & UAL one can only guess what BAML is thinking.
As many institutions have little-to-no exposure to AAL I would say that will continue to change, limiting downside risk & keeping profit taking in check.
Get your facts up to date. It's all out there you just have to get out of your dog house & get it.
GSK owns a substantial piece of THRX equity---you can hopefully figure out why. The THRX CEO has been trying to defend his turf valiantly & deserves credit for his efforts. The key catalyst is what GSK wants to do. People are giving -- for now --- a pass on the slow market uptake by GSK on the THRX product approvals. As they know that it will be interesting to see what plans GSK has in store.
Little rookie----WHO are the INSIDERS you reference ????????????? It is NOT officers of THLD who actually work---it's the penny stock scavengers that you disparage like Willy Jaegar who have made up the BULK of the "insiders". Feel free to post ANY officer(s) who owns 19% ---- not gonna happen. Even Sellick is not a big player ----certainly for his tenure at THLD ( dozen years+++). PLEASE FEEL FREE TO POST ANY FACTS YOU CAN DRUM UP. Or .... better yet----as you are a rookie putz retail---just keep posting more nonsense. IF YOU WANT TO POST FACTS----please feel free. BUT YOU CAN'T. Insiders include the Willys who bought penny stock.....or is THAT too complicated for little beachbaby ? Pick a side ----can't have it both ways.
Just get in the game & do some homework. Don't tell us that you're some old flee-infested mutt that relies on yahoo to provide factual information. Sure wouldn't be surprising but there is data out there that provides real information. But ....like most things......you probably wouldn't know what to do with it.
You still thinking about dog training school ? I think you should ! You just might learn something----imagine that !!
Hey Woofy---are you counting the venture cap vulture buyers who were able to buy penny stock & get board seats like Willy Jaegar & Sutter Hill when THLD was out begging for $$$ ? Take a closer look at the corporate officers of THLD----very small holdings. CEO Sellick has a small position for someone who's been there over a dozen years. Institutions are falling over themselves owning shares ????? Are you all there ??? Do some homework or you'll have to go back into your cage. Looks like you're drinking the same kool-aid as that that other cheerleader. Try to get in the game !
little pup thanks for the wonderful update ! you've cleared why the institutions have been ramping up their positions ! you should mate with little rookie beachball---that would be a biological treat to see ! can only imagine the "logic" that would come out of that creation. sure sounds like biotechs & market analysis is way over your pedigree. now go back to the pound & play with the other mutts.
It's always nice but JPM has been involved as a shareholder for some time & have even lowered their position over the last year. It will likely be perceived more positively when an active sector professional org ( ex Baker Brothers) bothers to put $$$ to work in THLD. Right now the biotech professionals remain on the sideline. My experience is that they will wait & pay up if the data warrants it as they are skeptical overall. They are happy to let retail sit & hold until/if the science validates. Institutions will have no problem paying $10-15/sh if the picture is clearer.
What do YOU think ? Maybe GSK wants only a part of the corporate portfolio & that by splitting GSK only has to buy what they want ??
The stock has about doubled over the last year --- have you failed to notice ? I am very happy with THRX's performance as it has significantly outperformed.Also, those large cap biotechs you noted all have approved products & billions$$ of revenues.
JPM went over the 5% hurdle---now owns 5.3% (3.16 MM shares) as of 12/31
ALERT----Beachball Rookie has proclaimed...."the shorts have left" !!! What a hoot ! Now it's...."option manipulation" on this micro-cap !!! What will little rookie come up with next ???? Stay tuned for more info from the SELF PROCLAIMED THLD MARKET SAVANT.
Just IMAGINE if little rookie knew what he-She was talking about !!!! PLEASE keep the all-too-frequent pontifications coming ! They provide many with daily humor---that I'm SURE !
AAL is underowned institutionally----both in the transportation as well as airline sector---as many were unable to be involved with the bankrupt AAMRPQ & chose to be involved in UAL/DAL et al. So there are a number of reasons why AAL has material upside this year.
AAL is a differentiated story in this outperforming sector. Management has shown a proven track record of merger integration (though not on this scale). That brings interest to the table. Also, there continues to be a ground swell supporting the investment theme that rational industry pricing & cost controls --- probably not EVER seen in this sector ---- allows investors who have always avoided airlines (" only trading stocks" ) to invest in the sector. I would add it's possible you could also see funds earmarked for other transports finding a home in the new AAL as well.
AAL has arguably as much if not more earnings leverage than DAL & UAL in 2014. This allow both the EPS estimates & multiple paid for their earnings to increase. Instead of $3--3.50 '14 est @ 8-10 multiple you have a decent shot @ 10-12 X $4-4.25 earnings power. This scenario provides the potential of 50% upside this year & a $50 type stock over the next 12-15 months.
Throw in a decent fuel environment and this is the bet I am making.
You would know if you saw his targets & compensation agreements. As you may be inexperienced in any of this you can be forgiven. That would not be surprising at all as you clearly do not have experience or insight in this area. Not sure it you pay much attention or not but we shareholders have seen a double in our stock price over the last year......did you miss that ? Any remote reason why that happened ???? Are you familiar with THRX or new to the company ??????
Hey rookie---why are you all consumed about short sellers ? You have such limited investment experience & knowledge based on your constant rantings that maybe it's time you seek counsel or at the very least do some homework on the subject. It's tiring to see such dribble based on limited information. Maybe you've appointed yourself as the THLD HALL MONITOR-----if so get in the game & learn the investment business so you don't constantly come off as a house shrill. Grow up & grow a pair of little one.